methergin 0,2 mg/ml injektionsvæske, opløsning
essential pharma limited - methylergometrinhydrogenmaleat - injektionsvæske, opløsning - 0,2 mg/ml
miacalcic 100 ie/ml injektions-/infusionsvæske, opløsning
essential pharma (m) limited - calcitonin (laks) - injektions-/infusionsvæske, opløsning - 100 ie/ml
felden 20 mg dispergible tabletter
pfizer aps - piroxicam - dispergible tabletter - 20 mg
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
petidin "dak" 100 mg suppositorier
takeda pharma a/s - pethidinhydrochlorid - suppositorier - 100 mg
atropin "dak" 1 mg/ml injektionsvæske, opløsning
takeda pharma a/s - atropinsulfat - injektionsvæske, opløsning - 1 mg/ml
cetraxal comp ukonserveret 3+0,25 mg/ml øredråber, opløsning i enkeltdosisbeholder
poa pharma scandinavia ab - ciprofloxacinhydrochlorid (monohydrat), fluocinolonacetonid - øredråber, opløsning i enkeltdosisbeholder - 3+0,25 mg/ml
fragmin 10.000 anti-xa ie/ml injektionsvæske, opløsning
pfizer aps - dalteparinnatrium - injektionsvæske, opløsning - 10.000 anti-xa ie/ml
fragmin 10.000 anti-xa ie injektionsvæske, opløsning i fyldt injektionssprøjte
pfizer aps - dalteparinnatrium - injektionsvæske, opløsning i fyldt injektionssprøjte - 10.000 anti-xa ie
fragmin 12.500 anti-xa ie injektionsvæske, opløsning i fyldt injektionssprøjte
pfizer aps - dalteparinnatrium - injektionsvæske, opløsning i fyldt injektionssprøjte - 12.500 anti-xa ie